EU OKs first-line use of AZ’ Faslodex
admin 27th July 2017 Uncategorised 0EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.
More: EU OKs first-line use of AZ’ Faslodex
Source: News